Related Experiment Video
Updated: Jan 4, 2026

04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
29.4K
A frontal-vagal network theory for Major Depressive Disorder: Implications for optimizing neuromodulation techniques
Tabitha A Iseger1, Nienke E R van Bueren2, J Leon Kenemans2
1Department of Experimental Psychology, Utrecht University, Utrecht, the Netherlands; Research Institute Brainclinics, Nijmegen, the Netherlands.
Brain Stimulation
|November 1, 2019
Summary
Major Depressive Disorder (MDD) is linked to heart issues. A new frontal-vagal network model suggests heart rate (HR) and heart rate variability (HRV) can guide neuromodulation treatments for depression.
Area of Science:
- Neuroscience
- Psychiatry
- Cardiology
Background:
- Major Depressive Disorder (MDD) frequently co-occurs with cardiovascular disease.
- Depressed patients often exhibit elevated heart rate (HR) and reduced heart rate variability (HRV).
Purpose of the Study:
- To propose a frontal-vagal network model linking brain function to cardiovascular changes in MDD.
- To review neuromodulation studies targeting brain regions implicated in depression and their effects on HR/HRV.
- To explore the utility of the frontal-vagal network for understanding depression pathways and guiding neuromodulation.
Main Methods:
- Review of existing literature on MDD, cardiovascular comorbidity, and neuromodulation.
- Analysis of studies targeting key brain nodes like the dorsolateral prefrontal cortex (DLPFC) and subgenual anterior cingulate cortex (sgACC).
- Examination of vagus nerve (VN) stimulation effects.
- Presentation of a meta-analysis of Neuro-Cardiac-Guided Transcranial Magnetic Stimulation (NCG-TMS) studies.
Main Results:
- The proposed frontal-vagal network integrates brain and heart activity in MDD.
- Neuromodulation targeting specific brain regions impacts HR and HRV.
- NCG-TMS demonstrates consistent HR deceleration during frontal stimulation and acceleration during motor strip stimulation, supporting its role in target engagement.
Conclusions:
- Incorporating HR and HRV measurements is crucial for depression research, especially in neuromodulation studies.
- The frontal-vagal network offers a framework for individualizing neuromodulation treatments like rTMS.
- NCG-TMS shows promise as a method for assessing target engagement in neuromodulation therapies for depression.
Keywords:
Dorsolateral prefrontal cortexHeart rateHeart rate variabilityMajor depressive disorderNeuro-cardiac-guided TMSNeuromodulationSubgenual anterior cingulate cortexTarget engagementVagus nerveMore Related Videos
Related Concept Videos
Depression: Overview
723
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
723
Depressive Disorders: Etiology
398
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
398
Antidepressant Drugs: MAOIs and Other Agents
741
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
741

